๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pancreatic Cancer, Adult

A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers NCT07769502Phase 27 sites๐Ÿ“ Hattiesburg๐Ÿ“ Ramat Gan๐Ÿ“ Jerusalem AbbVie ยท Tests: Telisotuzumab Adizutecan, Gemcitabine, Nab-Paclitaxel Surveillance of Pancreatic Health After Diabetes Diagnosis NCT06803771NA31 sites๐Ÿ“ Sandbach๐Ÿ“ Maidstone๐Ÿ“ Leicester University Hospital Southampton NHS Foundation Trust ยท Tests: Avantect Pancreatic Cancer Test A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites๐Ÿ“ Newport Beach๐Ÿ“ Stanford๐Ÿ“ Miami Eli Lilly and Company ยท Tests: LY4337713 BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079Phase 117 sites๐Ÿ“ Los Angeles๐Ÿ“ Sacramento๐Ÿ“ San Diego TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) ยท Tests: BBO-11818, Pembrolizumab, Platinum chemotherapy (cisplatin or carboplatin), Pemetrexed, Cetuximab Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI NCT04954599Phase 1, Phase 25 sites๐Ÿ“ Brussels๐Ÿ“ Ghent๐Ÿ“ Maastricht Maastricht University Medical Center ยท Tests: CP-506, Carboplatin, Immune checkpoint inhibitor Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers NCT05779917Phase 11 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: CAR-T cells DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Dabrafenib, Trametinib Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer NCT07436741Phase 31 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: surufatinib + gemcitabine + nab-paclitaxel, gemcitabine + nab-paclitaxel A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations NCT06835569Phase 114 sites๐Ÿ“ Orlando๐Ÿ“ Tampa๐Ÿ“ Boston Alterome Therapeutics, Inc. ยท Tests: ALTA3263, cetuximab, mFOLFOX6, Pembrolizumab, Pemetrexed + Cisplatin /Carboplatin Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors NCT06218914Phase 118 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach AstraZeneca ยท Tests: NT-112: Autologous, engineered T Cells targeting KRAS G12D, AZD0240: Autologous, engineered T Cells targeting KRAS G12D Pancreatic Cancer Screening for At-risk Individuals NCT05006131n/a1 site๐Ÿ“ Boston Beth Israel Deaconess Medical Center ยท Tests: Screening for pancreatic cancer A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. NCT07903415Phase 12 sites๐Ÿ“ Grand Rapids๐Ÿ“ San Antonio Pfizer ยท Tests: PF-08098488 Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors NCT06005493Phase 1, Phase 225 sites๐Ÿ“ Jacksonville๐Ÿ“ Rochester๐Ÿ“ New York AstraZeneca ยท Tests: AZD5863, AZD2936 GPC3/Mesothelin-CAR-ฮณฮดT Cells Against Cancers NCT06196294Phase 11 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Cell therapy for solid tumors Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer NCT06747481n/a1 site๐Ÿ“ Las Palmas de Gran Canaria University of Las Palmas de Gran Canaria Resilience and Equity in Aging, Cancer, and Health (REACH) NCT04674267NA1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Phase 2 Intervention - Geriatric Co-Management Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer NCT03977233Phase 21 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Oxaliplatin, Leucovorin, Irinotecan Hydrochloride, 5-FU A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors NCT07094204Phase 122 sites๐Ÿ“ Santa Monica๐Ÿ“ Atlanta๐Ÿ“ Jefferson Astellas Pharma Inc ยท Tests: ASP5834, panitumumab A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539Phase 12 sites๐Ÿ“ Taichung๐Ÿ“ Tainan LaunXP Biomedical Co., Ltd. ยท Tests: LXP1788 is administered intravenously via Port-A A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation. NCT06008288Phase 231 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Beijing Allist Pharmaceuticals, Inc. ยท Tests: JAB-21822 A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors NCT06598007Phase 1, Phase 21 site๐Ÿ“ Houston Crossignal Therapeutics, Inc. ยท Tests: CT3001, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) Intravital Microscopy in Human Solid Tumors NCT03823144NA1 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Diagnostic Microscopy, Fluorescein Sodium Injection A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression NCT06051695Phase 1, Phase 212 sites๐Ÿ“ Gilbert๐Ÿ“ La Jolla๐Ÿ“ Los Angeles A2 Biotherapeutics Inc. ยท Tests: A2B694, A2B543, xT CDx with HLA-LOH Assay A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Miami Astellas Pharma Global Development, Inc. ยท Tests: ASP546C A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation NCT05877599Phase 120 sites๐Ÿ“ Gilbert๐Ÿ“ Duarte๐Ÿ“ Los Angeles AstraZeneca ยท Tests: NT-175 A Study Evaluating a New Radiation Treatment Workflow (NGDS) NCT07824583NA2 sites๐Ÿ“ St Louis๐Ÿ“ Cleveland Varian, a Siemens Healthineers Company ยท Tests: Next Generation Delivery System (NGDS) InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Samples SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites๐Ÿ“ Glen Burnie๐Ÿ“ Pittsburgh๐Ÿ“ Seoul SK Life Science, Inc. ยท Tests: SKL35501, SKL35502 Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan NCT05005403Phase 148 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Los Angeles AbbVie ยท Tests: Azirkitug, Budigalimab, Bevacizumab, Telisotuzumab Adizutecan
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy